Development and Execution of High-Content Imaging Assays
$827,811ZICFY2014CANIH
Division Of Basic Sciences - Nci
Investigators
Linked publications & trials
Paper 39117696Paper 38866555Paper 38724854Paper 38717453Paper 38529487Paper 38502483Paper 38502482Paper 38464289Paper 38448539Paper 38359982Paper 37219077Paper 37210724Paper 37129573Paper 37094694Paper 35819192Paper 35764396Paper 35428779Paper 35353576Paper 33979654Paper 33592464Paper 31421980Paper 31085625Paper 30799036Paper 30238154Paper 30091656Paper 29408376Paper 28615324Paper 27528272Paper 27259148Paper 26997247Paper 26774352Paper 26686465Paper 26472748Paper 26313373Paper 26276637Paper 26104467Paper 25916843Paper 25633629
Abstract
The HiTIF is currently involved in 14 collaborative projects with NCI intramural Research Investigators. The current HCI projects run at HiTIF cover many different basic research areas that are important for cancer research: - DNA Damage Response (DDR) - Etiology of DNA translocations in live cells - Cellular pathways involved in pediatric neuroblastoma - Epigenetics of DNA translocations - Nuclear hormone biology and regulation of gene expression - RNA splicing - Premature aging disease. The HiTIF is open to assist NCI and NIH investigators in the design, optimization, implementation and analysis of High-Content Imaging assays for the systematic study of cancer-relevant cellular phenotypes.
View original record on NIH RePORTER →